Significantly Lower Serum Adiponectin Levels in the Postmenopausal Age may be Specific for Breast Cancer Risk

Creative Commons License

AKSOY T., Trabulus D. C., Aral H., Serin E., Talu C. K.

ISTANBUL MEDICAL JOURNAL, vol.21, no.5, pp.355-361, 2020 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 5
  • Publication Date: 2020
  • Doi Number: 10.4274/imj.galenos.2020.92979
  • Journal Name: ISTANBUL MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.355-361
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Introduction: To date, biomarkers have played a minimal role in the early diagnosis of breast cancer. Although its effects on metabolism are not well known, studies have shown that hypoadiponectinaemia is associated with increased insulin resistance and risk for type-2 diabetes. We aimed to investigate the value of adiponectin together with laboratory results, anthropometric measurements and histopathological findings in assessing the risk of breast cancer and for use in early diagnosis.